-
Ugeskrift for laeger · Jul 2003
[Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
- Jens Erik Nielsen-Kudsk.
- Kardiologisk Afdeling B, Skejby Sygehus, Aarhus Universitetshospital, DK-8200 Arhus N. jenk@dadlnet.dk
- Ugeskr. Laeg. 2003 Jul 14; 165 (29): 2891-4.
AbstractBlockade of endothelin receptors is a new drug principle for the treatment of pulmonary arterial hypertension. Bosentan is a competitive blocker of endothelin receptors administered by the oral route. In clinical trials it has been shown to increase the functional capacity of patients with pulmonary arterial hypertension. This article describes the background, results of clinical trials, and practical guidelines for the use of bosentan in pulmonary arterial hypertension.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..